Letrozole in Preventing Breast Cancer in Healthy Postmenopausal Women at

Status Completed

Clinical Trial Summary

This randomized phase I trial studies the side effects and the best dose of letrozole in preventing breast cancer in healthy postmenopausal women at high risk for breast cancer. Chemoprevention is the use of drugs to keep breast cancer from forming or coming back. The use of letrozole may keep cancer from forming in healthy postmenopausal women at high risk for breast cancer.

Clinical Trial Description

PRIMARY OBJECTIVES:

I. Compare the effect of lower and intermittent doses of letrozole to standard letrozole therapy on estrogen suppression in postmenopausal women at high risk for developing breast cancer.

SECONDARY OBJECTIVES:

I. Comparison of the effect of lower and intermittent doses of letrozole to standard therapy on signs and symptoms of estrogen deficiency, including menopausal symptoms, serum lipid profile, and serum marker of bone turnover.

II. Comparison of the effect of lower and intermittent doses of letrozole to standard therapy on nuclear chromatin abnormality of breast epithelial cells collected by random periareolar fine needle aspiration (RPFNA).

TERTIARY OBJECTIVES:

I. Determine the prevalence of breast cancer stem cells in the fine needle breast aspirates and explore the potential intervention effect on the prevalence of breast cancer stem cells.

OUTLINE: Patients are randomized to 1 of 4 treatment arms.

ARM I: Patients receive 2.5 mg of letrozole orally (PO) thrice weekly for 6 months.

ARM II: Patients receive 1.0 mg of letrozole PO thrice weekly for 6 months.

ARM III: Patients receive 0.25 mg of letrozole PO thrice weekly for 6 months.

ARM IV: Patients receive 2.5 mg of letrozole PO once daily for 6 months.

After completion of study treatment, patients are followed up at week 30. ;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01077453
Study type	Interventional
Source	National Cancer Institute (NCI)
Contact
Status	Completed
Phase	Phase 1
Start date	March 2010

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01950403` - Linaclotide Acetate in Preventing Colorectal Cancer in Healthy Volunteers	Phase 1
Terminated	`NCT01336387` - Dose-Finding of Retinoid 9cUAB30 in Healthy Volunteers	Phase 1
Terminated	`NCT01561989` - Cholecalciferol and Flu Vaccine in Treating Healthy Participants	N/A
Completed	`NCT01140646` - Evaluation of SAMe for Hot Flashes	Phase 2
Completed	`NCT00892515` - Exercise Programs in Healthy Young Women at Increased Risk of Developing Breast Cancer	N/A
Completed	`NCT00450957` - Lycopene in Healthy Male Participants	Phase 1
Completed	`NCT00365209` - Phase II A Trial of Curcumin Among Patients With Prevalent Subclinical Neoplastic Lesions (Aberrant Crypt Foci)	Phase 2
Recruiting	`NCT04445532` - Hepatobiliary Tumors Tissue Samples Acquisition
Completed	`NCT02100254` - Narrative or Fact-Based Videos in Increasing Colorectal Cancer Screenings in African American Communities	N/A
Completed	`NCT02129517` - Web-Based Tailored Educational Program in Improving Nurse Communication With Patients About Clinical Trials	N/A
Terminated	`NCT01755208` - Light-Scattering Spectroscopy for Detection of Breast Cancer	N/A
Completed	`NCT00392652` - Diindolylmethane in Healthy Volunteers	Phase 1
Completed	`NCT00499460` - Effects of Garlic Supplements on Opioids in Healthy Volunteers	Phase 4
Completed	`NCT00478309` - Genetic Epidemiology Risk Assessment Program or Usual Care in Colorectal Cancer Screening for Healthy Participants	N/A
Completed	`NCT01370889` - Resveratrol in Postmenopausal Women With High Body Mass Index	Phase 1
Completed	`NCT00896207` - Studying Different Formulations of SR13668 in Healthy Volunteers	Phase 1
Completed	`NCT00679094` - Bowman-Birk Inhibitor Concentrate in Healthy Men	Phase 1
Terminated	`NCT02154984` - Time Restricted Diet in Obese or Overweight Pre or Postmenopausal Participants	N/A
Completed	`NCT00489372` - Se-Methyl-Seleno-L- Cysteine (MSC) in Treating Healthy Patients	Phase 1
Completed	`NCT00513916` - Effect of Dietary Soy on Estrogens in Breast Fluid, Blood, and Urine Samples From Healthy Women	Phase 3

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Letrozole in Preventing Breast Cancer in Healthy Postmenopausal Women at High Risk for Breast Cancer

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms